US Stock MarketDetailed Quotes

AMIX Autonomix Medical

Watchlist
  • 0.640
  • -0.002-0.23%
Close Jul 5 16:00 ET
  • 0.600
  • -0.040-6.20%
Post 19:52 ET
12.06MMarket Cap-781P/E (TTM)

Autonomix Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-258.58%-6.65M
-268.87%-2.29M
-1.85M
-620K
Net income from continuing operations
-675.18%-15.43M
-723.14%-5.41M
---1.99M
---657K
Operating gains losses
--8M
--3.03M
----
----
Depreciation and amortization
--81K
--46K
--0
--0
Change In working capital
-41.91%79K
-656.76%-206K
--136K
--37K
-Change in payables and accrued expense
338.58%557K
-627.03%-195K
--127K
--37K
-Change in other current assets
-5,411.11%-478K
---11K
--9K
--0
Cash from discontinued investing activities
Operating cash flow
-258.58%-6.65M
-268.87%-2.29M
---1.85M
---620K
Investing cash flow
Cash flow from continuing investing activities
-19K
-3K
0
0
Net PPE purchase and sale
---19K
---3K
--0
--0
Cash from discontinued investing activities
Investing cash flow
---19K
---3K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
2,034.81%14.41M
1,334.07%9.68M
675K
675K
Net issuance payments of debt
--2M
--0
--0
--0
Net common stock issuance
1,930.52%13.71M
1,509.78%10.87M
--675K
--675K
Net other financing activities
---1.3M
---1.19M
----
----
Cash from discontinued financing activities
Financing cash flow
2,034.81%14.41M
1,334.07%9.68M
--675K
--675K
Net cash flow
Beginning cash position
-57.68%865K
50.37%1.22M
--2.04M
--810K
Current changes in cash
756.74%7.74M
13,336.36%7.39M
---1.18M
--55K
End cash Position
895.14%8.61M
895.14%8.61M
--865K
--865K
Free cash flow
-259.60%-6.67M
-269.35%-2.29M
---1.85M
---620K
Currency Unit
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(FY)Mar 31, 2023(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -258.58%-6.65M-268.87%-2.29M-1.85M-620K
Net income from continuing operations -675.18%-15.43M-723.14%-5.41M---1.99M---657K
Operating gains losses --8M--3.03M--------
Depreciation and amortization --81K--46K--0--0
Change In working capital -41.91%79K-656.76%-206K--136K--37K
-Change in payables and accrued expense 338.58%557K-627.03%-195K--127K--37K
-Change in other current assets -5,411.11%-478K---11K--9K--0
Cash from discontinued investing activities
Operating cash flow -258.58%-6.65M-268.87%-2.29M---1.85M---620K
Investing cash flow
Cash flow from continuing investing activities -19K-3K00
Net PPE purchase and sale ---19K---3K--0--0
Cash from discontinued investing activities
Investing cash flow ---19K---3K--0--0
Financing cash flow
Cash flow from continuing financing activities 2,034.81%14.41M1,334.07%9.68M675K675K
Net issuance payments of debt --2M--0--0--0
Net common stock issuance 1,930.52%13.71M1,509.78%10.87M--675K--675K
Net other financing activities ---1.3M---1.19M--------
Cash from discontinued financing activities
Financing cash flow 2,034.81%14.41M1,334.07%9.68M--675K--675K
Net cash flow
Beginning cash position -57.68%865K50.37%1.22M--2.04M--810K
Current changes in cash 756.74%7.74M13,336.36%7.39M---1.18M--55K
End cash Position 895.14%8.61M895.14%8.61M--865K--865K
Free cash flow -259.60%-6.67M-269.35%-2.29M---1.85M---620K
Currency Unit USDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday-0.19%